Proteomics: a major new technology for the drug discovery process.

Proteomics: a major new technology for the drug discovery process.

Proteomics is a new enabling technology that is being integrated into the drug discovery process. This will facilitate the systematic analysis of proteins across any biological system or disease, forwarding new targets and information on mode of action, toxicology and surrogate markers. Proteomics i...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Page, M, Amess, B, Rohlff, C, Stubberfield, C, Parekh, R
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	1999

Gelijkaardige items

Applying genomic and proteomic microarray technology in drug discovery /
door: 224468 Matson, Robert S.
Gepubliceerd in: (c201)

Applying genomic and proteomic microarray technology in drug discovery /
door: 224468 Matson, Robert S.
Gepubliceerd in: (2004)

Tissue proteomics : pathways, biomarkers, and drug discovery /
door: Liu, Brian C.-S., et al.
Gepubliceerd in: (2008)

Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties.
door: Page, M, et al.
Gepubliceerd in: (1999)

Comparative genomics and proteomics in drug discovery /
door: Parrington, John, et al.
Gepubliceerd in: (2006)

Bioinformatics methods and applications : genomics, proteomics and drug discovery /
door: 384476 Rastogi, S. C., et al.
Gepubliceerd in: (c200)

Proteomic comparison of human and great ape blood plasma reveals conserved glycosylation and differences in thyroid hormone metabolism.
door: Gagneux, P, et al.
Gepubliceerd in: (2001)

Discovery of Screening Biomarkers for Major Depressive Disorder in Remission by Proteomic Approach
door: Hyebin Choi, et al.
Gepubliceerd in: (2021-03-01)

Chemical Proteomics Applied to Target Identification and Drug Discovery
door: Steven H.L. Verhelst, et al.
Gepubliceerd in: (2005-02-01)

Aptamer-based multiplexed proteomic technology for biomarker discovery.
door: Larry Gold, et al.
Gepubliceerd in: (2010-12-01)

The Drug Discovery and Development Process in the New Millennium
door: Michael D Levy
Gepubliceerd in: (2000-01-01)

Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD
door: Thomas J. Hedl, et al.
Gepubliceerd in: (2019-06-01)

Process optimization in drug discovery
door: Roberts, Rebecca Anne, M.B.A. Massachusetts Institute of Technology
Gepubliceerd in: (2007)

Proteomics for biological discovery /
door: 183962 Veenstra, Timothy D., et al.
Gepubliceerd in: (2006)

Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics
door: Mingjie Zou, et al.
Gepubliceerd in: (2024-07-01)

Editorial: Mass spectrometry-based proteomics in drug discovery and development
door: Martin Pejchinovski, et al.
Gepubliceerd in: (2024-07-01)

Systematic in silico Evaluation of Leishmania spp. Proteomes for Drug Discovery
door: Crhisllane Rafaele dos Santos Vasconcelos, et al.
Gepubliceerd in: (2021-04-01)

Drug Discovery Process
door: Kenichi KUWASHIMA
Gepubliceerd in: (2016-05-01)

Technologies for Proteome-Wide Discovery of Extracellular Host-Pathogen Interactions
door: Nadia Martinez-Martin
Gepubliceerd in: (2017-01-01)

Knowledge discovery in proteomics /
door: 193240 Jurisica, Igor, et al.
Gepubliceerd in: (2006)

Discovery of new liver fibrosis markers in hepatitis C patients using proteomics
door: Gangadharan, B, et al.
Gepubliceerd in: (2011)

Patient-derived tumoroids and proteomic signatures: tools for early drug discovery
door: Hélène Lê, et al.
Gepubliceerd in: (2024-04-01)

Production of Proteins of the SARS-CoV‑2 Proteome for Drug Discovery
door: Choon Kim, et al.
Gepubliceerd in: (2021-07-01)

Cysteine-specific Chemical Proteomics: From Target Identification to Drug Discovery
door: Dominic G. Hoch, et al.
Gepubliceerd in: (2016-11-01)

Deep proteome profiling promotes whole proteome characterization and drug discovery for esophageal squamous cell carcinoma
door: Wei Liu, et al.
Gepubliceerd in: (2022-03-01)

Proteome discovery pipeline for mass spectrometry-based proteomics
door: Buck Charles R, et al.
Gepubliceerd in: (2008-07-01)

The Major Role of Clinicians in the Discovery of Off-Label Drug Therapies
door: DeMonaco, Harold J., et al.
Gepubliceerd in: (2005)

Acanthocheilonema viteae: phosphorylcholine is attached to the major excretory-secretory product via an N-linked glycan.
door: Harnett, W, et al.
Gepubliceerd in: (1993)

Drug discovery and development: technology in transition
door: Hill, RG, et al.
Gepubliceerd in: (2021)

Drug discovery and development : technology in transition /
door: Rang, H. P.
Gepubliceerd in: (2006)

SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
door: Xiaonan Liu, et al.
Gepubliceerd in: (2021-10-01)

Proteomic Approaches in Biomarker Discovery: New Perspectives in Cancer Diagnostics
door: Petra Hudler, et al.
Gepubliceerd in: (2014-01-01)

Quality not Quantity: The Role of Marine Natural Products in Drug Discovery and Reverse Chemical Proteomics
door: Andrew M. Piggott, et al.
Gepubliceerd in: (2005-06-01)

Proteomics for cancer biomarker discovery
door: Volchenboum, Samuel Louis
Gepubliceerd in: (2008)

Proteomics Discovery of Disease Biomarkers
door: Mamoun Ahram, et al.
Gepubliceerd in: (2008-01-01)

Proteomics Discovery of Disease Biomarkers
door: Mamoun Ahram, et al.
Gepubliceerd in: (2008-01-01)

New drug discovery and development /
door: Lednicer, Daniel, 1929-
Gepubliceerd in: (2007)

New drug discovery: Where are we heading to?
door: M R Yadav
Gepubliceerd in: (2013-01-01)

Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.
door: Fischer, R, et al.
Gepubliceerd in: (2012)

Epigenetic protein families: a new frontier for drug discovery.
door: Arrowsmith, C, et al.
Gepubliceerd in: (2012)